Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
A recent study carried out by Frédéric Darios in the team led by Alexis Brice at the Institut du Cerveau - ICM highlights the importance of spatacsin, a protein affected in pathologies such as hereditary spastic paraplegia.
The neuromuscular junction is a zone that enables transfer of information from the nervous system to muscles, and is affected in Amyotrophic Lateral Sclerosis. The team led by Edor Kabashi at the Institut du Cerveau – ICM focused on the role of...
Serotonin is a neuromodulator, meaning a molecule produced by neurons that modulates communication between other neurons in our brain. Serotonin has many functions that, for some, remain unclear. It is involved in regulation of behaviors, mood...
0808Xavier Briffault is a social science researcher specialized in healthcare at the CNRS-CERMES3 and is involved in the Crazy App and Altotoc projects with the team led by Luc Mallet at the Institut du Cerveau - ICM. He recently wrote a book...
Why does multiple sclerosis progress more rapidly in some patients than in others? Why do some patients with multiple sclerosis succeed in repairing demyelination damage over the course of the disease and others not? A joint study led by Institut du...
In a new study, Mariam Chammat, post-doctoral researcher (FRM) and Prof Lionel Naccache (AP-HP, UPMC), team leader at the Institut du Cerveau, found that the renowned psychological phenomenon known as cognitive dissonance is closely linked to...
Myelin, a protective sheath that covers various nerve fibers, is essential in the transmission of nerve signals and enables proper function of the nervous system. Myelin degeneration causes severe illnesses including multiple sclerosis. Lamia...
From the early stages of Parkinson’s disease onwards, cardiovascular and respiratory disorders are relatively frequent. The team led by Stéphane Lehéricy and Marie Vidailhet at the Institut du Cerveau – ICM highlighted, for the very first time, a...
Nicolas Renier, a new team leader at the Institut du Cerveau - ICM, joined the Institute on the 1st January 2017. His work focuses on changes of connections between neurons in adulthood, using a new technique: 3D brain imaging through light-sheet...
The publication of Benedetta Bodini and Bruno Stankoff, researchers at Paris Brain Institute, on the use of a new imaging technique in multiple sclerosis, was selected by Lancet Neurology among the top 5 of 2016 to improve the understanding and...
A stage 3 clinical trial has proven the efficacy of lacosamide alone to treat focal seizures, specifically as a first-line treatment for newly diagnosed epilepsy.
Researchers from the “Experimental therapeutics of neurodegeneration” team led by Etienne Hirsch at the Brain and Spine Institute – Institut du Cerveau - ICM, Institut du Cerveau et de la Moelle épinière – and collaborators, have just published a...
